Mattiasson I, Berntorp E, Bornhov S, Lagerstedt C, Lethagen S, Persson J, Timberg I, Torstensson I
Department of Vascular and Renal Diseases, Lund University, University Hospital, Malmö, Sweden.
Int Angiol. 1998 Sep;17(3):146-50.
To assess whether uncomplicated deep vein thrombosis could be treated in an out-patient setting without increasing the frequency of complications, and to determine the proportion of patients with deep vein thrombosis, traditionally treated as in-patients at the Departments of Medicine, who are eligible for such treatment.
In a multicentre study, carried out at six hospitals of varying sizes and serving a population of about 600,000, consecutive patients over 18 years of age, with verified deep vein thrombosis, primarily presented as acute cases at the respective Departments of Medicine, were considered for treatment on an out-patient basis during a 1-year period.
Those eligible for out-patient treatment were put on low molecular weight heparin and oral anticoagulants, and scheduled for daily attendance at the out-patient clinic of the respective Dept. of Medicine. Details of any complication were recorded according to a standard check-list. The patients underwent a full checkup at three-month follow-up.
Any bleeding event or pulmonary embolism. Progress of thrombosis.
Of 523 patients considered for out-patient treatment, 126 (24%) were excluded according to the defined exclusion criteria, 197 (38%) were treated entirely on an out-patient basis, and another 43 (8%) were initially treated in hospital (median two days) before being transferred to the out-patient setting. Three patients had to be hospitalized for suspected complications, but none of these turned out to be serious. No serious bleeding event or thromboembolic complication was registered.
Uncomplicated acute deep vein thrombosis could be safely treated on an out-patients basis. At least 50% of the patients with this diagnosis, former treated as in-patients at the Depts. of Medicine, are eligible for such treatment.
评估无并发症的深静脉血栓形成是否可在门诊治疗而不增加并发症发生率,并确定传统上在内科作为住院患者治疗的深静脉血栓形成患者中符合此类治疗条件的比例。
在一项多中心研究中,于六家规模各异、服务人口约60万的医院开展,纳入18岁以上经证实患有深静脉血栓形成且主要作为急性病例在各内科就诊的连续患者,在1年期间考虑进行门诊治疗。
符合门诊治疗条件的患者接受低分子量肝素和口服抗凝剂治疗,并安排每天到各内科门诊就诊。根据标准检查表记录任何并发症的详细情况。患者在三个月随访时进行全面检查。
任何出血事件或肺栓塞。血栓形成进展情况。
在考虑门诊治疗的523例患者中,根据既定排除标准排除126例(24%),197例(38%)完全在门诊治疗,另有43例(8%)最初在医院治疗(中位时间为两天),之后转至门诊治疗。3例患者因疑似并发症住院,但均未出现严重情况。未记录到严重出血事件或血栓栓塞并发症。
无并发症的急性深静脉血栓形成可在门诊安全治疗。至少50%诊断为此病的患者,以往在内科作为住院患者治疗,符合此类治疗条件。